新闻稿

Intrasense opens its share capital to the Guerbet Group, which announces its intent to file a voluntary tender offer under the same price conditions

11 1月 2023

Intrasense (FR0011179886 - ALINS), a specialist in medical imaging software solutions ("Intrasense" or the "Company") announces that the Guerbet Group (FR0000032526 - GBT) has acquired a 39% stake in its share capital through a reserved share capital increase for a total amount of 8.8 million euros at an issuance price of 0.44 euro per share, representing a premium of 34.15% over the last closing price of the shares of Intrasense (the "Capital Increase").

发现更多

2022-half-year results: continued growth momentum

12 10月 2022

Intrasense (FR0011179886 - ALINS), specialist in medical imaging software solutions and developer of Myrian® (the "Group"), today announces its 2022 IFRS Group consolidated half-year financial results.

发现更多

Intrasense signs a historic contract with Brazilian medical technology leader MV

11 10月 2022

Intrasense (FR0011179886 - ALINS), a specialist in medical imaging software solutions, and MV, a key global player in the development of healthcare management software, announced the signing of a new contract to deploy the innovative solutions of the Myrian platform in Brazil, Panama, Colombia and Argentina.

发现更多

Intrasense attends the 70th edition of the "Journées Francophones de Radiologie" 

29 9月 2022

Intrasense (FR0011179886 - ALINS), specialist in medical imaging software solutions and developer of Myrian®, is pleased to announce its participation in the Journées Francophones de Radiologie (JFR). The exhibition will be held at the Palais des Congrès in Paris. The 2022 edition is dedicated to the continuity of care pathways and to "digital health". This international medical imaging congress will gather more than 10,000 visitors between October 7 and 10

发现更多

Intrasense signs a strategic partnership with Nurea

1 6月 2022

Intrasense (FR0011179886 - ALINS), specialist in medical imaging software solutions, and Nurea, a leading provider of decision support and diagnostic software for vascular diseases, announce the signing of a partnership that will make Nurea's artificial intelligence solution available to clinicians within the
Myrian platform, through the Intrasense AI Hub.

发现更多

Intrasense launches its AI Hub in partnership with Milvue

17 5月 2022

Intrasense (FR0011179886 - ALINS), specialist in medical imaging software solutions, announces, in partnership with the company Milvue, the first integration of a solution within its Hub dedicated to artificial intelligence. The AI Hub enables the simple and ergonomic integration of artificial intelligence algorithms and their orchestration within clinical applications to better meet the
needs of users.

发现更多

Availability of the 2021 annual financial report

20 4月 2022

Intrasense (FR0011179886 - ALINS), specialist in medical imaging software
solutions and designer of Myrian®, announces today the publication of its Annual
Financial Report for the year ended December 31, 2021. This Annual Financial
Report was approved by the Board of Directors on April 19, 2022.

发现更多

TeleDiag chooses Intrasense by signing a commercial contract for teleradiology

5 4月 2022

Intrasense (FR0011179886 - ALINS), specialist in medical imaging software solutions and designer of Myrian®, and TeleDiag, a leading player in teleradiology in France entered into a partnership for the deployment of the Myrian® platform to strengthen clinical efficiency and the management of cancer patients.

发现更多

Intrasense 2021 results: record business growth

10 3月 2022

Intrasense (FR0011179886 - ALINS), a specialist in medical imaging software solutions and designer of Myrian®, is today publishing audited 2021 consolidated IFRS financial statements for the Group.

发现更多

Intrasense and Forcomed sign a five-year strategic partnership agreement

1 2月 2022

Intrasense and Forcomed, a leading provider of continuing medical education, have entered into a five-year partnership to enable radiologists and radiology technicians to use Myrian® during a new training module on breast imagin.

发现更多
1 2 3 9
订阅